Smiths Group (LON:SMIN) had its target price boosted by analysts at JPMorgan Chase & Co. from GBX 1,300 ($16.00) to GBX 1,500 ($18.46) in a report issued on Wednesday, ThisIsMoney.Co.Uk reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 6.23% from the company’s current price.
Several other research analysts have also recently weighed in on SMIN. Liberum Capital restated a “hold” rating on shares of Smiths Group in a research note on Tuesday. Citigroup restated a “buy” rating on shares of Smiths Group in a report on Tuesday, April 7th. Barclays reaffirmed an “overweight” rating on shares of Smiths Group in a research report on Monday, May 18th. Goldman Sachs Group lifted their price target on Smiths Group from GBX 1,520 ($18.71) to GBX 1,580 ($19.44) and gave the company a “buy” rating in a research note on Tuesday. Finally, Royal Bank of Canada upgraded Smiths Group to an “outperform” rating and cut their price objective for the stock from GBX 1,690 ($20.80) to GBX 1,300 ($16.00) in a research note on Thursday, March 19th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of GBX 1,491 ($18.35).
Shares of LON SMIN opened at GBX 1,412 ($17.38) on Wednesday. The company has a market cap of $5.15 billion and a P/E ratio of 22.48. The company has a quick ratio of 0.92, a current ratio of 2.76 and a debt-to-equity ratio of 66.83. The business has a 50-day simple moving average of GBX 1,296.07 and a two-hundred day simple moving average of GBX 1,420.62. Smiths Group has a 52 week low of GBX 790 ($9.72) and a 52 week high of GBX 2,246.40 ($27.64).
Smiths Group Company Profile
Smiths Group plc operates as a technology company severing the medical technology, security and defense, general industrial, oil and gas, and space and commercial aerospace markets worldwide. The company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek.
Featured Story: How can investors find ex-dividend dates?
Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.